# Ultragenyx Pharmaceutical Inc. (RARE) — Cash on Hand

## Annual Cash on Hand (USD)

| Year | Cash on Hand |
| --- | --- |
| 2025 | $421M |
| 2024 | $174M |
| 2023 | $214M |
| 2022 | $133M |
| 2021 | $308M |
| 2020 | $714M |
| 2019 | $434M |
| 2018 | $113M |
| 2017 | $100M |
| 2016 | $161M |

Source: [CompaniesByCap](https://companiesbycap.com/company/RARE/cash-on-hand)